Kura Oncology, Inc. announced a private placement of 1,376,813 shares of its common stock at a price of $17.25 per share and pre paid warrants at a price of $17.2499 for the total gross proceeds of $150,000,000 on January 24, 2024. The pre paid warrant will be exercisable into common shares at a price of $0.0001. The private placement is expected to close on or about January 26, 2024, subject to customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.65 USD | +3.42% | +12.09% | +36.65% |
Apr. 22 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
Apr. 22 | Kura Oncology Gets Breakthrough Designation For Leukemia Therapy | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.65% | 1.5B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology, Inc. announced that it expects to receive $150 million in funding from EcoR1 Capital, LLC